Trypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental Model

Trypanosoma brucei gambiense is the main causative agent of Human African Trypanosomiasis (HAT), also known as sleeping sickness. Because of limited alternatives and treatment toxicities, new therapeutic options are urgently needed for patients with HAT. Sterol 14alpha-demethylase (CYP51) is a poten...

Descripción completa

Detalles Bibliográficos
Autores principales: Dauchy, Frédéric-Antoine, Bonhivers, Mélanie, Landrein, Nicolas, Dacheux, Denis, Courtois, Pierrette, Lauruol, Florian, Daulouède, Sylvie, Vincendeau, Philippe, Robinson, Derrick R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113867/
https://www.ncbi.nlm.nih.gov/pubmed/27855164
http://dx.doi.org/10.1371/journal.pntd.0005125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113867/
https://www.ncbi.nlm.nih.gov/pubmed/27855164
http://dx.doi.org/10.1371/journal.pntd.0005125

Ejemplares similares